Literature DB >> 3293853

Features of renal vasculitis in autoimmune MRL lpr/lpr mice: phenotypes and functional properties of infiltrating cells.

A Tarkowski1, R Jonsson, R Sanchez, L Klareskog, W J Koopman.   

Abstract

MRL lpr/lpr (MRL/1) mice spontaneously develop a widespread renal vasculitis. The majority of the cells in vasculitic lesions are bright Ly-1, L3T4 and la-positive in contrast to the cells found in lymph nodes and spleens of the old MRL/1 mice. However, despite differences in phenotypical patterns, B and T cells from arteritic lesions do not differ from mononuclear cells (MNC) eluted from MRL/1 lymph nodes with regard to the frequency of IgG secreting cells and the proliferative responses to Concanavalin A (Con A). Co-culture experiments with congeneic MRL+/+ (MRL/n) spleen cells indicate that the poor response to Con A of the MNC eluted from vasculitic lesions is, unlike the case of lymph node MNC, due to suppressive action of vasculitic cells on the indicator cell population. Further support for the activation status of infiltrating MHC in kidney vasculitic lesions, expressed by high in vivo uptake of 3H-thymidine, was obtained by autoradiography performed on frozen sections. The observed differences in phenotypic patterns and functional features between lymph node MNC and infiltrating vasculitic MNC indicate that different immune mechanisms may be responsible for the development of lymphadenopathy and vasculopathy, respectively in MRL/1 mouse.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3293853      PMCID: PMC1541495     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Pathogenesis of serum sickness.

Authors:  F J DIXON; J J VAZQUEZ; W O WEIGLE; C G COCHRANE
Journal:  AMA Arch Pathol       Date:  1958-01

2.  The proliferating cells in autoimmune MRL/lpr mice lack L3T4, an antigen on "helper" T cells that is involved in the response to class II major histocompatibility antigens.

Authors:  D Wofsy; R R Hardy; W E Seaman
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

3.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

4.  Murine synovial intima contains I-A-, I-E/C-positive bone-marrow-derived cells.

Authors:  L Klareskog; U Forsum; H Wigzell
Journal:  Scand J Immunol       Date:  1981-05       Impact factor: 3.487

5.  Detection of IgG rheumatoid factor secreting cells in autoimmune MRL/1 mice: a kinetic study.

Authors:  A Tarkowski; C Czerkinsky; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

6.  A sensitive method for the detection of specific antibody production in different isotypes from single lamina propria plasma cells.

Authors:  N Lycke
Journal:  Scand J Immunol       Date:  1986-10       Impact factor: 3.487

7.  Local cellular immune response in ascending urinary tract infection: occurrence of T-cells, immunoglobulin-producing cells, and Ia-expressing cells in rat urinary tract tissue.

Authors:  E M Hjelm
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

8.  Proliferating cells in the synovial fluid in rheumatic disease. An analysis with autoradiography-immunoperoxidase double staining.

Authors:  V Bergroth; Y T Konttinen; P Nykänen; R von Essen; K Koota
Journal:  Scand J Immunol       Date:  1985-10       Impact factor: 3.487

9.  A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.

Authors:  A Pierres; P Naquet; A Van Agthoven; F Bekkhoucha; F Denizot; Z Mishal; A M Schmitt-Verhulst; M Pierres
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

10.  Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains.

Authors:  B S Andrews; R A Eisenberg; A N Theofilopoulos; S Izui; C B Wilson; P J McConahey; E D Murphy; J B Roths; F J Dixon
Journal:  J Exp Med       Date:  1978-11-01       Impact factor: 14.307

View more
  8 in total

1.  Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

Authors:  H Loppnow; P Libby
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

2.  Therapeutic effect of 15-deoxyspergualin on the progression of lupus nephritis in MRL mice. I. Immunopathological analyses.

Authors:  S Ito; M Ueno; M Arakawa; T Saito; T Aoyagi; M Fujiwara
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 3.  Lessons from animal models of vasculitis.

Authors:  I G Luzina; B S Handwerger
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

4.  Differential effects of captopril and enalapril, two angiotensin converting enzyme inhibitors, on immune reactivity in experimental lupus disease.

Authors:  A Tarkowski; H Carlsten; H Herlitz; G Westberg
Journal:  Agents Actions       Date:  1990-08

5.  Efficient analysis of mouse genome sequences reveal many nonsense variants.

Authors:  Sophie Steeland; Steven Timmermans; Sara Van Ryckeghem; Paco Hulpiau; Yvan Saeys; Marc Van Montagu; Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-04       Impact factor: 11.205

6.  Oestrogen is a potent disease accelerator in SLE-prone MRL lpr/lpr mice.

Authors:  H Carlsten; A Tarkowski; R Holmdahl; L A Nilsson
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

7.  A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus.

Authors:  O T Chan; L G Hannum; A M Haberman; M P Madaio; M J Shlomchik
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

Review 8.  Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.

Authors:  J B Weinberg
Journal:  Environ Health Perspect       Date:  1998-10       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.